Characterization and Cytotoxicity Studies of the Rare 21:4 n-7 Acid and Other Polyunsaturated Fatty Acids from the Marine Opisthobranch Scaphander lignarius, Isolated Using Bioassay Guided Fractionation
The marine opisthobranch Scaphander lignarius has been analyzed in the systematic search for novel bioactive compounds in Arctic marine organisms using bioassay guided fractionation. A number of highly cytotoxic fractions were shown to contain mainly polyunsaturated fatty acids (PUFAs). Selected PUFAs were isolated and identified using both liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR). It was shown that the opisthobranch contained unusual PUFAs such as several ω3 fatty acids and the ω7 heneicosa-5,8,11,14-tetraenoic acid (21:4 n-7) not isolated before. The organism was shown to be a very rich source of PUFAs and the activity of the isolated compounds against a range of human cancer cell lines (melanoma, colon carcinoma and breast carcinoma) is further reported. The ω7 PUFA was significantly more cytotoxic in comparison with reference ω6 arachidonic and ω3 eicosapentaenoic acid. A noteworthy non-selective cytotoxicity against normal lung fibroblasts was also established. The paper contains isolation protocols in addition to cytotoxicity data of the isolated compounds. The potential of marine mollusks as a source for rare PUFAs is also discussed.
References
[1]
Paterson, I.; Anderson, E.A. The renaissance of natural products as drug candidates. Science 2005, 310, 451–453, doi:10.1126/science.1116364.
[2]
Gerwick, W.H.; Moore, B.S. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem. Biol. 2012, 19, 85–98, doi:10.1016/j.chembiol.2011.12.014.
[3]
Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69–85, doi:10.1038/nrd2487.
[4]
Svenson, J. MabCent: Arctic marine bioprospecting in Norway. Phytochem. Rev. 2012, doi:10.1007/s11101-012-9239-3.
[5]
Berge, J.P.; Barnathan, G. Fatty acids from lipids of marine organisms: Molecular biodiversity, roles as biomarkers, biologically active compounds, and economical aspects. In Marine Biotechnology I; Gal, Y.L., Ulber, R., Eds.; Springer-Verlag: Berlin, Germany, 2005; Volume 96, pp. 49–125.
[6]
Benkendorff, K.; Davis, A.R.; Rogers, C.N.; Bremner, J.B. Free fatty acids and sterols in the benthic spawn of aquatic molluscs, and their associated antimicrobial properties. J. Exp. Mar. Biol. Ecol. 2005, 316, 29–44, doi:10.1016/j.jembe.2004.10.001.
[7]
Das, U.N. Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 2011, 30, 311–324, doi:10.1007/s10555-011-9316-x.
[8]
Riccardi, G.; Giacco, R.; Rivellese, A.A. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin. Nutr. 2004, 23, 447–456, doi:10.1016/j.clnu.2004.02.006.
[9]
Harris, W.S. N-3 Fatty acids and serum lipoproteins: Human studies. Am. J. Clin. Nutr. 1997, 65, 645–654.
[10]
Rivellese, A.A.; Maffettone, A.; Iovine, C.; DiMarino, L.; Annuzzi, G.; Mancini, M.; Riccardi, G. Long-Term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 1996, 19, 1207–1213.
[11]
Menendez, J.A.; Lupu, R.; Colomer, R. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6 n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur. J. Cancer Prev. 2005, 14, 263–270, doi:10.1097/00008469-200506000-00011.
[12]
Calviello, G.; Serini, S.; Piccioni, E.; Pessina, G. Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: Preventive and therapeutic strategies. Nutr. Cancer 2009, 61, 287–301, doi:10.1080/01635580802582777.
[13]
Bougnoux, P.; Hajjaji, N.; Ferrasson, M.N.; Giraudeau, B.; Couet, C.; Le Floch, O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: A phase II trial. Br. J. Cancer 2009, 101, 1978–1985, doi:10.1038/sj.bjc.6605441.
[14]
Rezanka, T.; Sigler, K. Odd-Numbered very-long-chain fatty acids from the microbial, animal and plant kingdoms. Prog. Lipid Res. 2009, 48, 206–238, doi:10.1016/j.plipres.2009.03.003.
[15]
Bouchet, P.; Rocroi, J.P.; Fryda, J.; Hausdorf, B.; Ponder, W.; Valdes, A.; Waren, A. Classification and nomenclator of gastropod families. Malacologia 2005, 47, 1–368.
[16]
Cutignano, A.; Avila, C.; Domenech-Coll, A.; d’Ippolito, G.; Cimino, G.; Fontana, A. First biosynthetic evidence on the phenyl-containing polyketides of the marine mollusc Scaphander lignarius. Org. Lett. 2008, 10, 2963–2966.
[17]
Cimino, G.; Spinella, A.; Sodano, G. Potential alarm pheromones from the mediterranean opisthobranch Scaphander lignarius. Tetrahedron Lett. 1989, 30, 5003–5004, doi:10.1016/S0040-4039(01)80566-9.
[18]
Cutignano, A.; Avila, C.; Rosica, A.; Romano, G.; Laratta, B.; Domenech-Coll, A.; Cimino, G.; Mollo, E.; Fontana, A. Biosynthesis and cellular localization of functional polyketides in the gastropod mollusc Scaphander lignarius. Chembiochem 2012, 13, 1759–1766, doi:10.1002/cbic.201200287.
[19]
Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461–477, doi:10.1021/np068054v.
[20]
Paterson, I.; Findlay, A.D. Recent advances in the total synthesis of polyketide natural products as promising anticancer agents. Aust. J. Chem. 2009, 62, 624–638, doi:10.1071/CH09104.
[21]
Johns, R.B.; Nichols, P.D.; Perry, G.J. Fatty-Acid components of 9 species of mollusks of the littoral-zone from Australian waters. Comp. Biochem. Phys. B 1980, 65, 207–214, doi:10.1016/0305-0491(80)90004-8.
[22]
Saito, H. Unusual novel n-4 polyunsaturated fatty acids in cold-seep mussels (Bathymodiolus japonicus and Bathymodiolus platifrons), originating from symbiotic methanotrophic bacteria. J. Chromatogr. A 2008, 1200, 242–254.
[23]
Barnathan, G. Non-Methylene-Interrupted fatty acids from marine invertebrates: Occurrence, characterization and biological properties. Biochimie 2009, 91, 671–678, doi:10.1016/j.biochi.2009.03.020.
[24]
Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005, 4, 206–220, doi:10.1038/nrd1657.
[25]
Connor, W.E. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 2000, 71, 171S–175S.
[26]
Nagao, K.; Yanagita, T. Conjugated fatty acids in food and their health benefits. J. Biosci. Bioeng. 2005, 100, 152–157, doi:10.1263/jbb.100.152.
[27]
Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024–1033, doi:10.1001/2012.jama.11374.
[28]
Das, U.N. Gamma-linolenic acid, arachidonic-acid, and eicosapentaenoic acid as potential anticancer drugs. Nutrition 1990, 6, 429–434.
[29]
Wendel, M.; Heller, A.R. Anticancer actions of omega-3 fatty acids—Current state and future perspectives. Anti-Cancer Agents Med. Chem. 2009, 9, 457–470, doi:10.2174/1871520610909040457.
[30]
Das, U.N. Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clin. Lipid. 2011, 6, 463–489, doi:10.2217/clp.11.34.
[31]
Carballeira, N.M. New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog. Lipid Res. 2008, 47, 50–61, doi:10.1016/j.plipres.2007.10.002.
[32]
Dunbar, L.M.; Bailey, J.M. Enzyme deletions and essential fatty-acid metabolism in cultured-cells. J. Biol. Chem. 1975, 250, 1152–1153.
[33]
Babior, B.M.; Kipnes, R.S.; Curnutte, J.T. Biological defense mechanisms—production by leukocytes of superoxide a potential bactericidal agent. J. Clin. Invest. 1973, 52, 741–744, doi:10.1172/JCI107236.
Huang, P.; Feng, L.; Oldham, E.A.; Keating, M.J.; Plunkett, W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000, 407, 390–395, doi:10.1038/35030140.
[36]
Das, U.N. Tumoricidal action of cis-unsaturated fatty-acids and their relationship to free-radicals and lipid-peroxidation. Cancer Lett. 1991, 56, 235–243, doi:10.1016/0304-3835(91)90008-6.
[37]
Makarieva, T.N.; Santalova, E.A.; Gorshkova, I.A.; Dmitrenok, A.S.; Guzii, A.G.; Gorbach, V.I.; Svetashev, V.I.; Stonik, V.A. A new cytotoxic fatty acid (5Z,9Z)-22-methyl-5,9-tetracosadienoic acid and the sterols from the far eastern sponge Geodinella robusta. Lipids 2002, 37, 75–80, doi:10.1007/s11745-002-0866-6.
[38]
Das, U.N.; Prasad, V.; Reddy, D.R. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett. 1995, 94, 147–155, doi:10.1016/0304-3835(95)03844-M.
[39]
Saito, H. Characteristics of fatty acid composition of the deep-sea vent crab, Shinkaia crosnieri Baba and Williams. Lipids 2011, 46, 723–740, doi:10.1007/s11745-011-3549-x.
[40]
Nechev, J.; Christie, W.W.; Robaina, R.; De Diego, F.; Popov, S.; Stefanov, K. Chemical composition of the sponge Hymeniacidon sanguinea from the Canary Islands. Comp. Biochem. Phys. A 2004, 137, 365–374, doi:10.1016/j.cbpb.2003.10.016.
[41]
Chang, K.J.L.; Dunstan, G.A.; Abell, G.C.J.; Clementson, L.A.; Blackburn, S.I.; Nichols, P.D.; Koutoulis, A. Biodiscovery of new Australian thraustochytrids for production of biodiesel and long-chain omega-3 oils. Appl. Microbiol. Biotechnol. 2012, 93, 2215–2231, doi:10.1007/s00253-011-3856-4.
[42]
Gao, P.; Hirano, T.; Chen, Z.; Yasuhara, T.; Nakata, Y.; Sugimoto, A. Isolation and identification of C-19 fatty acids with anti-tumor activity from the spores of Ganoderma lucidum (reishi mushroom). Fitoterapia 2012, 83, 490–499, doi:10.1016/j.fitote.2011.12.014.
